|
Index of reports
> Cases with Febrile Neutropenia (100)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neulasta (Pegfilgrastim) where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 100 Next >>
Possible Neulasta side effects in female
Reported by a physician from Germany on 2012-08-27
Patient: female
Reactions: Drug Ineffective, Lymphopenia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Doxorubicin Hydrochloride; Prednisone TAB; Rituximab; Vincristine; Cyclophosphamide
Possible Neulasta side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin Hydrochloride
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Other drugs received by patient: MST / 00036302 /; Novalgin / 00169801 /; Rulid; Pantoprazole; Paspertin / 00041902 /; Acyclovir; Electrolytes NOS W / Macrogol 3350; Dipyrone INJ; Metoclopramide; Acyclovir
Possible Neulasta side effects in 50 year old female
Reported by a pharmacist from United Kingdom on 2012-08-23
Patient: 50 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Antineoplastic Agents; Ciprofloxacin
Possible Neulasta side effects in female
Reported by a physician from Germany on 2012-08-20
Patient: female
Reactions: Drug Ineffective, Lymphopenia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Doxorubicin HCL; Rituximab; Prednisone TAB; Cyclophosphamide; Vincristine
Possible Neulasta side effects in male
Reported by a health professional (non-physician/pharmacist) from Portugal on 2012-08-08
Patient: male
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Cisplatin; Bleomycin Sulfate; Etoposide
Possible Neulasta side effects in male
Reported by a consumer/non-health professional from Portugal on 2012-08-08
Patient: male
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Bleomycin Sulfate; Etoposide; Cisplatin
Possible Neulasta side effects in 64 year old male
Reported by a physician from Australia on 2012-08-03
Patient: 64 year old male
Reactions: Neutropenic Sepsis, Necrotising Colitis, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Cisplatin; Immunosuppressants; Etoposide
Possible Neulasta side effects in 64 year old male
Reported by a physician from Australia on 2012-08-01
Patient: 64 year old male
Reactions: Neutropenic Sepsis, Necrotising Colitis, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Cisplatin; Etoposide
Possible Neulasta side effects in
Reported by a physician from France on 2012-07-30
Patient:
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Fluorouracil; Docetaxel; Cisplatin
Possible Neulasta side effects in
Reported by a consumer/non-health professional from France on 2012-07-25
Patient:
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Docetaxel; Cisplatin; Fluorouracil
Possible Neulasta side effects in 52 year old female
Reported by a physician from United States on 2012-07-19
Patient: 52 year old female, weighing 52.0 kg (114.4 pounds)
Reactions: Febrile Neutropenia, Septic Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, one time dose
Indication: Neutropenia
Start date: 2012-03-04
End date: 2012-03-04
Neulasta
Indication: Chemotherapy
Other drugs received by patient: Adriamycin / 00330902 /; Cyclophosphamide
Possible Neulasta side effects in male
Reported by a consumer/non-health professional from Germany on 2012-07-09
Patient: male
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-04-06
End date: 2012-04-06
Rituximab
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-02
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Prednisolone
Dosage: 500 mg, qd
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-06
Other drugs received by patient: Novalgin / 00169801 /; Morphine Sulfate; Pantoprazole; Dipyrone TAB; Metoclopramide; Acyclovir
Possible Neulasta side effects in 46 year old male
Reported by a physician from United States on 2012-07-09
Patient: 46 year old male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Neulasta
Doxorubicin HCL
Vincristine
Neulasta
Indication: non-Hodgkin's Lymphoma
Mabthera
Start date: 2012-05-02
Mabthera
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine
Indication: non-Hodgkin's Lymphoma
Mesna
Cyclophosphamide
Dexamethasone
Administration route: Oral
Mesna
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Valtrex; Omeprazole; Fluconazole; Metoprolol; Morphine; Ciprofloxacin; MS Contin; Enoxaparin; Compazine
Possible Neulasta side effects in
Reported by a physician from United States on 2012-07-06
Patient:
Reactions: Stomatitis, Hepatic Failure, Palmar-Plantar Erythrodysaesthesia Syndrome, Febrile Neutropenia, Haematotoxicity, Cardiac Disorder, Neutropenia, Thrombocytopenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Neulasta
Dosage: on day 2 of a 14 day cycle
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: day 1-5
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: 2 mg max
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxil
Dosage: cohort 1: 20 mg/m2 cohort ii: 25 mg/m2 cohort iii: 30 mg/m2
Indication: Diffuse Large B-Cell Lymphoma
Possible Neulasta side effects in 60 year old female
Reported by a physician from United States on 2012-06-29
Patient: 60 year old female, weighing 66.2 kg (145.7 pounds)
Reactions: Drug Ineffective, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neulasta
Indication: Prophylaxis
Neulasta
Dosage: 6 mg, one time dose
Indication: Neutropenia
Start date: 2012-05-25
End date: 2012-05-25
Other drugs received by patient: Carboplatin; Pemetrexed; Bevacizumab
Possible Neulasta side effects in 63 year old female
Reported by a consumer/non-health professional from France on 2012-06-28
Patient: 63 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Dehydration, Febrile Neutropenia, Febrile Bone Marrow Aplasia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Start date: 2012-03-04
End date: 2012-03-27
Neulasta
Dosage: 6 mg, unk
Other drugs received by patient: Doxorubicin HCL; Vincristine Sulfate; Cyclophosphamide; Prednisolone; Rituximab
Possible Neulasta side effects in
Reported by a physician from United States on 2012-06-25
Patient:
Reactions: Bone Pain, Febrile Neutropenia
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Antineoplastic Agents
Possible Neulasta side effects in
Reported by a consumer/non-health professional from Romania on 2012-06-21
Patient:
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Neulasta
Possible Neulasta side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-12
Patient: female
Reactions: Drug Ineffective, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Etoposide; Cisplatin
Possible Neulasta side effects in male
Reported by a physician from Germany on 2012-06-11
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: Rulid; Electrolytes NOS W / Macrogol 3350; Acyclovir; Dipyrone TAB; Metoclopramide; Pantoprazole; MST / 00036302 /; Novalgin / 00169801 /; Paspertin / 00041902 /; Acyclovir
Possible Neulasta side effects in female
Reported by a consumer/non-health professional from Canada on 2012-06-11
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Cytoxan; Taxotere
Possible Neulasta side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-06-08
Patient: female
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Epirubicin; Fluorouracil; Cyclophosphamide; Docetaxel
Possible Neulasta side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05
Patient: female
Reactions: Febrile Neutropenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Indication: Neutropenia
Neupogen
Indication: Neutropenia
Neulasta
Indication: Anaemia
Other drugs received by patient: Antineoplastic Agents
Possible Neulasta side effects in male
Reported by a physician from Germany on 2012-06-03
Patient: male
Reactions: Aortic Aneurysm, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-04-16
Neulasta
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-04-20
Doxorubicin HCL
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-04-17
Vincristine
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-04-17
Prednisone
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-04-17
Cyclophosphamide
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-04-17
Other drugs received by patient: Simvastatin; Amiodarone HCL; Digitoxin TAB; Bisoprolol Fumarate; Simvastatin; Levothyroxine Sodium
Possible Neulasta side effects in 77 year old male
Reported by a physician from Denmark on 2012-05-29
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Other drugs received by patient: Pinex; Sulphamethizole; Valacyclovir Hydrochloride; Omeprazole
Possible Neulasta side effects in male
Reported by a physician from Germany on 2012-05-22
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Acyclovir
Dosage: 400 mg, unk
Administration route: Oral
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Cytoxan
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Other drugs received by patient: Acyclovir; Paspertin / 00041902 /; Metoclopramide; Rulid; Pantoprazole; Electrolytes NOS W / Macrogol 3350; Dipyrone TAB; MST / 00036302 /; Novalgin / 00169801 /
Possible Neulasta side effects in female
Reported by a physician from United States on 2012-05-16
Patient: female
Reactions: Bone Marrow Disorder, Adverse Drug Reaction, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Cyclophosphamide; Taxotere
Possible Neulasta side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-14
Patient: female, weighing 56.3 kg (123.9 pounds)
Reactions: Febrile Neutropenia, Cough
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Breast Cancer
Start date: 2012-02-07
End date: 2012-03-21
Cyclophosphamide
Dosage: 600 mg/m2, unk
Indication: Breast Cancer
Neulasta
Dosage: 6 mg, q2wk
Indication: Chemotherapy
Start date: 2012-02-08
End date: 2012-03-21
Other drugs received by patient: Adriamycin PFS
Possible Neulasta side effects in male
Reported by a physician from Germany on 2012-05-10
Patient: male
Reactions: Febrile Neutropenia, Neutropenia, Skin Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: Rulid; Metoclopramide; Pantoprazole; Electrolytes NOS W / Macrogol 3350; Novalgin / 00169801 /; MST / 00036302 /; Dipyrone TAB; Acyclovir; Paspertin / 00041902 /
Possible Neulasta side effects in
Reported by a physician from Greece on 2012-05-10
Patient: , weighing 40.0 kg (88.0 pounds)
Reactions: Bone Pain, Anaemia, Febrile Neutropenia, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Neulasta
Page 1 Next >>
|
